Publications by authors named "Michael Haude"

Background: Following cryoballoon ablation, 20%-30% of the patients show recurrent atrial fibrillation (AF) in long-term follow-up as a consequence of incomplete circumferential ablation lines. Patient selection using computer tomography angiography (CTA)-derived parameters might be feasible to assign patients for cryoballoon ablation according to pulmonary vein (PV) anatomy and topography.

Methods: We aimed to analyze the impact of anatomical and topographic PV parameters on the procedural outcome of cryoballoon PVI using a retrospective analysis of 106 patients with paroxysmal AF and preprocedural CTA.

View Article and Find Full Text PDF

Background: Third-generation resorbable magnesium scaffold (RMS) was developed with stronger mechanical properties and thinner struts compared to its predecessor. This study aimed to assess the influence of the OCT-derived underlying plaque characteristics on in-scaffold late lumen loss (LLL) in patients treated with RMS up to 12-months.

Methods: Patients enrolled in the BIOMAG-I trial and who underwent OCT imaging before and after the index procedure were included in the current analysis.

View Article and Find Full Text PDF

Robotic-assisted percutaneous coronary intervention (r-PCI) exemplifies the advancement of interventional cardiology by integrating robotics to improve procedural control, operator safety, and potentially patient outcomes. This is a brief history of the development of r-PCI and robotics in cardiac surgery. r-PCI is currently more common in elective PCI cases, where time and precision are prioritized, however, the progress that has been made in surgical robotics allows us to believe in rapid progress of robots dedicated to complex coronary lesions treatment.

View Article and Find Full Text PDF

Background: Right ventricular-to-pulmonary artery (RV-PA) coupling is an important predictor of long-term survival following transcatheter edge-to-edge repair. However, its impact on survival in patients undergoing indirect mitral annuloplasty is unknown. The study aimed to assess the impact of baseline RV-PA coupling on survival following indirect mitral annuloplasty in heart failure patients.

View Article and Find Full Text PDF

Background: Advancement in interventional techniques has significantly improved the ability of percutaneous coronary intervention (PCI) to treat complex coronary artery disease. Despite these advancements, coronary artery calcification poses a substantial challenge during PCI, contributing to increased risks of procedural complications, prolonged procedure duration, and an increase in radiation exposure dose for both patients and physicians. Recently, robotic PCI has emerged, allowing physicians to remotely control and deliver wires and catheters, leading to a notable reduction of the operator radiation exposure and a decrease in the risk of operator physical injuries such as back pain.

View Article and Find Full Text PDF
Article Synopsis
  • The BIOMAG-I study evaluated the first-in-human resorbable magnesium scaffold (DREAMS 3G) and showed positive outcomes for clinical results and late lumen loss after 12 months.
  • The current substudy looked into vascular healing parameters using optical coherence tomography (OCT) and intravascular ultrasound (IVUS), focusing on aspects like strut visibility and neointimal growth.
  • Results from 56 patients indicated that almost all scaffold struts became invisible by 12 months, with a favorable vascular healing response, including a significant decrease in protruding neointimal tissue.
View Article and Find Full Text PDF
Article Synopsis
  • The Supraflex Cruz sirolimus-eluting stent (SES) shows promising early healing properties and is effective for patients at high bleeding risk (HBR) undergoing percutaneous coronary intervention (PCI).
  • A study involving 1203 patients, with 38.7% classified as HBR, measured safety and efficacy through a composite endpoint, finding higher cardiovascular events in HBR patients compared to non-HBR ones (8.1% vs. 4.4%).
  • Results confirmed the Supraflex Cruz's non-inferiority in both HBR and non-HBR groups when compared to established stent trials, indicating it is a safe option for this patient population.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to evaluate how the initial composition of plaque affects late loss in the lumen after DREAMS 3G implantation and to compare plaque changes over 6 and 12 months.
  • 116 patients from the BIOMAG-I trial underwent imaging using optical coherence tomography (OCT) before and after the procedure, revealing that those with more fibrous tissue in their plaque initially had greater differences in lumen area after a year.
  • Results showed a significant reduction in lipid areas and an increase in fibrous tissue at follow-up, indicating favorable healing of coronary walls post-implantation.
View Article and Find Full Text PDF

Background: For patients with acute myocardial infarction (AMI), direct coronary angiography (CA) is recommended, while for non-AMI patients, the diagnostic work-up depends on clinical criteria. This analysis provides initial prospective German data for the degree of guideline-adherence (GL) in the use of CA on non-AMI patients presenting at the emergency department (ED) with suspected acute coronary syndrome (ACS) according to the 2015 ESC-ACS-GL. Furthermore the implications of the application of the 2020 ESC-ACS-GL recommendations were evaluated.

View Article and Find Full Text PDF

Background: The Carillon® Mitral Contour System® has been studied in 4 prospective controlled studies in the treatment of functional mitral regurgitation (FMR) where it has been found to reduce mitral regurgitation, reduce left ventricular and atrial volumes, and be associated with improvements in clinical parameters.

Aims: The CINCH post-market registry is designed to evaluate immediate, mid-term and long-term outcomes from a post-approval study of the Carillon® device evaluated in real-world practice.

Methods: The CINCH post-market registry is a single-arm study of percutaneous mitral annuloplasty with the Carillon device in patients with functional (secondary) mitral regurgitation and symptomatic congestive heart failure when utilized in real-world conditions.

View Article and Find Full Text PDF
Article Synopsis
  • The DREAMS 3G is a new coronary magnesium scaffold designed to match the performance of traditional drug-eluting stents (DES).
  • The BIOMAG-I study is a first-in-human trial that evaluates the safety and effectiveness of this scaffold with a follow-up period of up to 5 years.
  • Results showed that after 12 months, the scaffold demonstrated low rates of complications, confirming its safety and efficacy as a potential alternative to DES.
View Article and Find Full Text PDF

Background: Bioresorbable scaffolds have been developed to overcome the limitations of drug-eluting stents and to reduce long-term adverse events.

Aims: We aimed to assess the long-term safety and efficacy of a sirolimus-eluting resorbable magnesium scaffold to ensure its safe rollout into clinical routine.

Methods: BIOSOLVE-IV is a prospective, international, multicentre registry including more than 100 centres in Europe, Asia, and Asia-Pacific.

View Article and Find Full Text PDF

Background: A third-generation coronary drug-eluting resorbable magnesium scaffold (DREAMS 3G) was developed to enhance the performance of previous scaffold generations and achieve angiographic outcomes comparable to those of contemporary drug-eluting stents.

Methods: This prospective, multicenter, non-randomized, first-in-human study was conducted at 14 centers in Europe. Eligible patients had stable or unstable angina, documented silent ischemia, or non-ST-elevation myocardial infarction, and a maximum of two single de novo lesions in two separate coronary arteries with a reference vessel diameter between 2.

View Article and Find Full Text PDF

Background: With 900'000 coronary angiographies (CA) per year, Germany has the highest annual per capita volume in Europe. Until now there are no prospective clinical data on the degree of guideline-adherence in the use of CA in patients with suspected chronic coronary syndrome (CCS) in Germany.

Methods: Between January 2019 and August 2021, 458 patients with suspected CCS were recruited in nine German centres.

View Article and Find Full Text PDF
Article Synopsis
  • The DREAMS 3G, a third-generation resorbable scaffold, was compared to its predecessor, the Magmaris scaffold, focusing on how they degrade over time.
  • A study involved implanting 49 DREAMS 3G and 24 Magmaris scaffolds into mini swine, analyzing their degradation across several time points and finding that DREAMS 3G had significantly less structural discontinuity.
  • After one year, DREAMS 3G showed nearly complete degradation with calcium and aluminium phosphate as byproducts, indicating it may offer extended support despite having thinner struts compared to Magmaris.
View Article and Find Full Text PDF
Article Synopsis
  • The COMBO stent, developed by OrbusNeich Medical, combines sirolimus for reducing cell overgrowth with a special coating to attract endothelial progenitor cells for quicker healing after coronary procedures.
  • The Mega COMBO collaboration analyzed data from multiple studies involving 6,753 patients undergoing PCI with the COMBO stent, focusing on the rate of target lesion failure (TLF) and other related complications over a year.
  • Results showed a TLF rate of 4.6% and low stent thrombosis rates, indicating that the COMBO stent performs well and might be a viable option compared to other drug-eluting stents.
View Article and Find Full Text PDF

Background: We aimed to investigate the anatomical relationship of the coronary sinus (CS) and the mitral valve annulus (MVA) in patients with or without functional mitral regurgitation (FMR) using a multislice CT (MSCT) software to determine (a) the distance and angle of both CS and MVA plane and (b) the mitral annulus geometry.

Methods: A total of 215 patients with MSCT and CS to MVA topography evaluation were enrolled in this retrospective study.

Results: This patient cohort included 145 patients without FMR (67.

View Article and Find Full Text PDF

Objectives: We aimed to compare indirect mitral annuloplasty using the Carillon Mitral Contour System and edge-to-edge repair via MitraClip in atrial functional mitral regurgitation (aFMR).

Background: In patients with left ventricular dilation, both edge-to-edge repair and indirect mitral annuloplasty are effective in reducing mitral regurgitation, while no clinical trial has compared both interventional methods in aFMR.

Methods: In a retrospective single-center analysis, 41 patients with aFMR underwent either edge-to-edge mitral valve repair (MitraClip group, n = 20) or indirect annuloplasty (Carillon group, n = 21).

View Article and Find Full Text PDF
Article Synopsis
  • * It presents a review of existing literature, dividing the findings into two parts: the first covers the epidemiology and diagnosis of cardiovascular issues in COVID-19 patients, while the second will focus on treatment strategies in a future edition.
  • * The document serves as a resource rather than formal guidelines, reflecting current knowledge and clinical experiences, and emphasizes that recommendations may evolve with new research and should align with local healthcare advisories.
View Article and Find Full Text PDF

Background: Permanent drug-eluting stents are associated with a steady increase in late complications attributed to persistent inflammation and poor vessel remodelling. Bioresorbable scaffolds have been developed to overcome such long-term limitations by providing temporary vessel support and disappearing thereafter. We aimed to assess the long-term outcomes of an absorbable metallic scaffold at 5 years.

View Article and Find Full Text PDF